Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nicole Fram M.D.
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt Treating Pain, and inflamMation Following Cataract Surgery Compared to Topical Prednisolone Acetate 1%.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with clinically significant cataract and are planning to undergo non-complicated Clear Cornea Incision Cataract Extraction with Posterior Capsule IntraOcular Lens in one or both eyes
Are willing and able to comply with clinic visits and study related procedures
Are willing and able to sign the informed consent form
You may not be if
Under the age of 18 at the time of signing the Informed Consent Form
Pregnant or planning to become pregnant during the trial period
Have visual acuity potential of less than 20/30 as recorded by a Retinal Acuity Meter or Potential Acuity Meter glare testing
Have active infectious systemic disease
Have active infectious ocular or extraocular disease
Have punctal plug in the study eye
Have obstructed nasolacrimal duct in the study eye(s) (dacryocystitus)
Have known hypersensitivity to dexamethasone or are a known steroid responder
Have a history of ocular inflammation or macular edema
Has history of Laser Vision Correction (LASIK, PhotoRefractive Keratectomy) in the operated eye
Are currently being treated with immunomodulating agents in the study eye
Are currently being treated with immunosuppressants and/or oral steroids
Are currently being treated with corticosteroid implant (i.e Ozurdex)
Have a history of herpes simplex virus keratitis or present active bacterial, viral, or fungal keratitis in either eye
Have a history of complete punctal occlusion in one or both punctum
Currently using topical ophthalmic steroid medications
Are unwilling or unable to comply with the study protocol
Are determined by the Investigator to not be included for reasons not already specified (e.g., systemic, behavioral, or other ocular disease/abnormality) if the health of the subject or the validity of the study outcomes may be compromised by the subject's enrollment
Clareo Health | Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
